Two-photon Imaging of Microglial Processes' Attraction Toward ATP or Serotonin in Acute Brain Slices
January 31st, 2019
9.4K views
Microglia, the resident immune cells of the brain, respond quickly with morphological changes to modifications of their environment. This protocol describes how to use two-photon microscopy to study the attraction of microglial processes toward serotonin or ATP in acute brain slices of mice.
Overview
This study investigates the motility of microglia, the brain's resident immune cells, in response to environmental stimuli like serotonin and ATP. Using two-photon microscopy, acute brain slices from mice allow for real-time analysis of microglial process attraction. The protocol emphasizes a detailed approach to evaluate microglial behavior under various conditions.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Immunology
Background
- Microglia play essential roles in brain immunity and response to injuries.
- Characterizing their motility is crucial for understanding their actions in health and disease.
- Two-photon microscopy provides a powerful tool for visualizing dynamic cellular processes.
- Investigating how microglia respond to different compounds offers insights into their functional roles.
Purpose of Study
- To assess the directional motility of microglia using advanced imaging techniques.
- To explore the influence of specific signaling molecules, like ATP and serotonin, on microglial behavior.
- To provide a detailed protocol for other researchers to replicate the study.
Methods Used
- Two-photon microscopy utilized with acute brain slices.
- Mice are used as the biological model after inducing acute brain slice preparations.
- No multiomics workflows are reported in the study.
- The protocol includes a detailed timeline for preparation and imaging, emphasizing the use of chilled artificial cerebrospinal fluid (aCSF).
- Microglial responses are monitored under variable conditions with specific compounds applied via a pipette.
Main Results
- The protocol allows for the measurement of microglial responses to chemical stimuli.
- Injection of ATP shows varying fluorescence responses, indicating complex tissue interactions.
- Quantifying motility in three dimensions helps in assessing microglial behavior under different experimental setups.
- Fluorescence intensity changes provide insights into microglial functional dynamics.
Conclusions
- This study enables more profound insights into microglial cellular dynamics and responses to neurotransmitters.
- The detailed protocol serves as a framework for future research on microglial functions in various contexts.
- Understanding microglial behavior may lead to new therapeutic targets in neurodegenerative diseases.
Frequently Asked Questions
What are the advantages of using two-photon microscopy for this study?
Two-photon microscopy allows for deep tissue imaging with reduced phototoxicity, enabling real-time observation of microglial processes in live brain slices.
How is the acute brain slice preparation implemented?
Mice are used to obtain brain slices, which are prepared in a specific manner to maintain cellular integrity for imaging purposes.
What types of data are obtained from this method?
The main outcomes include imaging of microglial motility and fluorescence intensity changes in response to specific compounds like ATP and serotonin.
How can this method be adapted for other studies?
This method can be tailored by changing the chemical stimuli or adjusting imaging parameters to investigate other cellular responses in the brain.
Are there any limitations to this approach?
One limitation is the potential for tissue distortion when applying compounds, which may affect fluorescence readings. Careful control of variables is essential.
Executive Industry Relevance
This protocol enables quantitative assessment of microglial directional motility in response to ATP or serotonin, providing a mechanistic readout for neuroimmune target validation. By capturing real-time process attraction in acute brain slices, it supports early-stage de-risking of CNS targets involved in inflammatory pathways. The method offers translational continuity from discovery to preclinical evaluation of microglial modulators.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses about microglial chemotaxis toward purinergic or serotonergic signals.
- Operational Value: Enables functional validation of targets like P2Y receptors or 5-HT receptors in a native tissue context.
- Predictive Value: Supports target confidence by linking ligand exposure to directional motility as a phenotypic readout.
Screening & Assay Development
- Assay Readiness: Prepares validated microglial systems for compound screening using fluorescence-based motility tracking.
- Quantitative Output: Measures mean intensity changes in a defined region of interest over time to assess response magnitude.
- Reproducibility: Uses z-projection, drift correction, and ROI standardization to reduce variability across experiments.
Translational & Preclinical Research
- Disease Relevance: Models microglial activation states relevant to neurodegenerative and neuroinflammatory conditions.
- Preclinical Continuity: Bridges in vitro findings with ex vivo tissue responses before in vivo validation.
- Risk-Adjusted Decisions: Informs go/no-go criteria based on dose-dependent motility responses to candidate modulators.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target engagement screening to phenotypic validation in disease-relevant systems.
- Discovery Biology: Supports hypothesis testing of microglial receptor function through directional process movement.
- Screening: Delivers assay-ready tissue with standardized viability optimization for adult mouse slices.
- Analytics: Generates time-dependent fluorescence intensity data enabling statistical comparison of compound effects.
- Translational Research: Maintains microglial physiological state for hours, supporting preclinical biomarker alignment studies.
- Enterprise Reuse: Establishes a reusable platform for evaluating multiple CNS-active compounds on immune cell behavior.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in microglial activation pathways through direct visualization of process attraction.
- Operational Value: Enhances reproducibility via perfusion-stabilized chambers and standardized ROI analysis.
- Strategic Value: Improves capital efficiency by prioritizing targets with strong phenotypic motility responses.
- Portfolio Impact: Enables risk-adjusted advancement of immunomodulators based on functional neuroimmune engagement.
Implementation Considerations
- Requires expertise in two-photon microscopy and microglial identification in brain slices.
- Depends on perfusion systems and interface chambers to maintain slice viability, especially in adult tissue.
- Necessitates standardized ROI size (35-micrometer diameter) and z-step calibration for consistent intensity measurements.
- Involves compound delivery via micromanipulator-guided pipette to avoid tissue distortion artifacts.
- Limited by acute slice lifespan, which decreases with age and requires optimized aCSF and oxygenation.
Biopharma FAQs
Why does directional motility matter for microglial target validation?
Directional motility serves as a functional readout of microglial chemotactic response to stimuli like ATP or serotonin, enabling target validation through phenotypic observation of process attraction in native tissue.
How does isolating the independent variable (compound application) fit the discovery pipeline?
Applying ATP or serotonin via micropipette isolates the independent variable, allowing researchers to link specific ligand exposure to microglial response, supporting hypothesis-driven target screening.
What do quantitative dependent variable measurements enable in this assay?
Measuring mean fluorescence intensity over time in a defined ROI enables quantification of microglial process accumulation, providing a continuous readout for comparing compound potency and efficacy.
Why do replication requirements matter for cross-functional collaboration?
Replication via z-projection, drift correction, and standardized ROI ensures consistent data across labs, supporting reliable handoff between discovery biology and preclinical teams.
What statistical analysis capabilities are required before implementing this method?
The method requires baseline normalization, time-series intensity tracking, and group comparison tools to assess statistical significance of microglial responses to different compounds or antagonists.
